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Objectives. This study estimated the prevalence of violence during pregnancy in relation to HIV
infection.
Methods. Violence, current partnerships, and HIV risk behaviors were assessed among 336 HIV-
seropositive and 298 HIV-seronegative at-risk pregnant women.
Results. Overall, 8.9% of women experienced recent violence; 21.5% currently had abusive part-
ners. Violence was experienced by women in all partnership categories (range = 3.8% with nonabusive
partners to 53.6% with physically abusive partners). Neither experiencing violence nor having an abu-
sive partner differed by serostatus. Receiving an HIV diagnosis prenatally did not increase risk. Dis-
closure-related violence occurred, but was rare.
Conclusions. Many HIV-infected pregnant women experience violence, but it is not typically attrib-
utable to their serostatus. Prenatal services should incorporate screening and counseling for all women
at risk for violence. (Am J Public Health. 2002;92:367–370)
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Conservative estimates suggest that 4% to 8%
of women in the United States experience vio-
lence during pregnancy.1,2 Several factors sug-
gest that risk for violence may be even higher
for pregnant women with HIV infection.
Women with HIV are at increased risk for vio-
lence relative to the general population,3,4 per-
haps because demographic and behavioral
factors associated with HIV (e.g., poverty, drug
use, bartering sex) also increase a woman’s ex-
posure to violence.5–9 In addition, some HIV-
infected women may be at risk for violence
when their positive serostatus is disclosed.10–15
Because a large proportion of HIV infections
in women are diagnosed through routine pre-
natal screening,16–19 many disclosures may
occur during pregnancy. Moreover, modifica-
tions of obstetric and postpartum care to pre-
vent perinatal transmission (e.g., additional
medications, formula feeding)20,21 may make it
more difficult for women who are pregnant or
have recently given birth to keep their serosta-
tus private.
Data collected as part of the Perinatal
Guidelines Evaluation Project—HIV and
Pregnancy Study were used to examine the
prevalence of violence during pregnancy
among women with HIV and to ascertain if,
and in what way, violence might be related
to HIV serostatus. Specifically, seronegative
women were matched to seropositive women
on a number of demographic and HIV risk
characteristics also associated with risk for vi-
olence. Owing to concerns that widespread
prenatal screening for HIV might inadver-
tently increase women’s risk for negative so-
cial consequences such as violence, the im-
pact of receiving an HIV diagnosis during
pregnancy was assessed. Finally, the associa-
tion between recent violence and current
partnership category was assessed and, for
HIV-infected women, violence associated
specifically with partner serostatus disclosure
was examined.
METHODS
Between October 1996 and October 1998,
pregnant women receiving prenatal care (336
HIV-infected and 298 HIV-uninfected women)
were recruited from health departments and
clinics in Brooklyn, NY (n=224), Connecticut
(n=55), Miami, Fla (n=220), and North Car-
olina (n=135), either directly or through their
providers. All HIV-infected women at partici-
pating clinics were eligible. Eligible uninfected
women (those receiving services at the clinic
and testing negative for HIV during the cur-
rent pregnancy) were screened and matched
(±5%) to HIV-infected women within the
same state according to the frequency of the
following: sexual transmission risk behavior
(ever used crack, had sex with a man known to
use or suspected of using intravenous drugs, or
traded sex for drugs or money), intravenous
drug use, race/ethnicity, and timing of entry
into prenatal care. (The cohort and design
have been previously described.22)
Demographic, behavioral, and HIV-related
information was collected from women
through interviews (in English, Spanish, or
Haitian Creole) at 24 weeks or more into the
pregnancy. Violence during pregnancy, re-
ferred to as recent violence, was assessed by
asking women whether they had been “beaten,
physically attacked, or physically abused” or
“sexually attacked, raped, or sexually abused”
by anybody during the past 6 months. Rela-
tionship with an abusive partner was catego-
rized by asking women with a main male part-
ner how frequently, when upset, does he
“physically abuse or hurt you” or “verbally or
emotionally abuse you.” Women answering
“always,” “often,” or “sometimes” were consid-
ered to have an abusive main male partner.
Thus, we measured the proportion of women
who experienced acts of violence during the
specified period (regardless of perpetrator), or
who currently had an abusive intimate partner
(regardless of whether a violent act occurred
during pregnancy). HIV-infected women were
asked, “Does your partner know about your
HIV infection?” and “Did anything bad happen
when he found out about your HIV?”
RESULTS
Demographic and behavioral characteris-
tics of the HIV-infected sample reflected those
of the broader HIV epidemic among women
and, with few exceptions, were similar to
those of uninfected women (Table 1). Recent
violence was reported by 8.9% of women. All
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TABLE 1—Demographic, Behavioral, and Violence–Abuse Characteristics for All Women and
by HIV Serostatus: Perinatal Guidelines Evaluation Project—HIV and Pregnancy Study
Variable Total Sample (n = 634) HIV+ (n = 336) HIV– (n = 298) P
Demographic/Behavioral Characteristics
Mean age, y 27.8 28.3 27.2 .04
Race/ethnicity,a % .50
White 7.3 5.9 8.7
Hispanic 19.9 19.4 20.5
Black (non-Hispanic) 69.7 71.1 68.1
Other 3.2 3.6 2.3
Education, % .28
< High school 53.6 55.9 51.2
High school 24.2 24.5 23.9
> High school 22.2 19.6 24.9
Monthly household income, % .52
< $1000 76.0 75.0 77.2
≥ $1000 24.0 25.0 22.8
Employment outside the home, % .74
Yes 21.5 21.0 22.0
No 78.5 79.0 78.0
Income sources, %
Medicaid 86.6 86.0 87.2 .65
WIC 79.4 81.4 77.2 .19
Food stamps 49.8 57.8 40.9 .001
Disability 13.9 21.3 5.7 .001
Public assistance/welfare 29.7 33.2 25.8 .04
Family/partners 74.1 69.8 78.9 .01
No. of times moved in past year (mean) 1.1 0.97 1.24 .05
Gestational age at entry into prenatal carea .61
≥ 20 wk 14.7 14.0 15.4
< 20 wk 85.3 86.0 84.6
Sex risk (crack, sex with intravenous drug .41
using male, barter sex),a %
Yes 39.3 40.8 37.6
No 60.7 59.2 62.4
Drug risk (intravenous drug use ever),a % .09
Yes 4.9 6.3 3.4
No 95.1 93.7 96.6
Recent Violence and Partnership Category
Experienced recent physical or sexual violence,b % .13
Yes 8.9 7.3 10.7
No 91.1 92.7 89.3
Has a main male partner,c % .003
Yes 81.8 77.6 86.6
No 18.2 22.4 13.4
Characterization of main male partner,d %
Physically abusive 5.5 5.1 5.8 .72
Verbally/emotionally abusive 16.0 14.5 17.4 .36
Nonabusive 78.6 80.4 76.7 .31
Continued
but 1 woman who reported sexual violence
also reported physical violence. Most women
had a main male partner; 21.5% described
their partner as physically or verbally/emo-
tionally abusive. Violence was significantly as-
sociated with partnership category (highest
for physically abusive, lowest for nonabusive,
intermediate for verbally/emotionally abusive
or no partner), but almost three fourths of the
women who experienced violence were not
currently in a relationship with a physically
abusive partner (Table 2).
Neither violence nor having an abusive part-
ner differed according to serostatus (Table 1).
The proportion of women reporting violence
was not higher among the 142 seropositive
women diagnosed with HIV during the current
pregnancy (5.8%) than among seronegative
women (10.7%) or seropositive women with a
prior HIV diagnosis (9.4%). Of the 260 HIV-
infected women with main male partners, only
206 (79.2%) said that their partner knew
their serostatus. Of these, 20 (9.7%) indicated
that something bad happened when he found
out. One woman was physically assaulted by
her partner; 1 woman physically assaulted her
partner. Other common negative outcomes in-
cluded anger, depression, or shock (n=9) and
relationship problems or terminations (n=6).
DISCUSSION
Overall, 8.9% of pregnant women in this
study experienced recent violence. Although
this is only slightly higher than average propor-
tions previously reported,1 it confirms that vio-
lence against pregnant women is a significant
public health problem, endangering both the
woman and her fetus.23–32 Extrapolating from
the 6000 to 7000 yearly births to women in
the United States with HIV,33 we calculate that
violence likely affects somewhere between
528 and 616 HIV-infected pregnant women
each year. Although risk for violence did not
differ by serostatus, we do not yet know if vio-
lence has a different impact on HIV-infected
women, who are already at increased risk for
adverse birth outcomes,22,34,35 and who must
adhere to complex medication regimens during
pregnancy.21,36
Moreover, many more women may be at
risk for violence and its health-related conse-
quences, as 21.5% of the women in the study
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TABLE 1—Continued
Experienced recent violence or had a physically .053
or verbally/emotionally abusive partner,e %
Yes 22.1 19.1 25.5
No 77.9 80.9 74.5
Note. WIC = Special Supplemental Nutrition Program for Women, Infants, and Children.
aMatched in design.
bRecent violence means the woman experienced violence in the prior 6 months. Six women for whom violence data were
missing are excluded.
cOne woman for whom male partner data were missing is excluded.
dCategories are mutually exclusive and determined as a hierarchy. Five women with main male partners for whom data on
partner abusiveness were missing are excluded.
eOne woman for whom both violence and partner data were missing is excluded.
TABLE 2—Number and Proportion of Women Who Experienced Violence in Prior 6 Months,
by Characterization of Current Male Partner
Experienced Violence in Prior 6 mo
Total Sample (n = 623) HIV-Seropositive Women (n = 325) HIV-Seronegative Women (n = 298) P (HIV+/HIV–
No, n (%) Yes, n (%) No, n (%) Yes, n (%) No, n (%) Yes, n (%) Comparison)
Characterization of current main male partner
Physically abusive 13 (46.4) 15 (53.6)a 7 (53.8) 6 (46.2)a 6 (40.0) 9 (60.0)a .46
Verbally/emotionally abusive 71 (86.6) 11 (13.4)b 33 (89.2) 4 (10.8)b,c 38 (84.4) 7 (15.6)b .53
Nonabusive 383 (96.2) 15 (3.8)c 195 (97.5) 5 (2.5)c 188 (95.0) 10 (5.0)b .18
No main male partner 100 (88.0) 15 (12.0)b 66 (88.0) 9 (12.0)b 34 (85.0) 6 (15.0)b .65
Total 567 (91.0) 56 (9.0) 301 (92.6) 24 (7.4) 266 (89.3) 32 (10.7)
Overall χ23 for sample 85.6 (P < .0001) 38.5 (P < .0001) 11.1 (P < .001)
a,b,cAmong the 6 pairwise comparisons within each sample (i.e., physically abusive vs verbally/emotionally abusive, physically abusive vs nonabusive, physically abusive vs no main male partner,
verbally/emotionally abusive vs nonabusive, verbally/emotionally abusive vs no main male partner, and nonabusive vs no main male partner), proportions in a column not sharing the same
superscript letter are significantly different at P < .008 (Bonferroni correction for 6 comparisons).
currently had an abusive primary partner. Not
surprisingly, women with a physically abusive
partner were most likely to experience recent
violence. However, many women whose part-
ner was not physically abusive, and even
those without a partner, experienced vio-
lence. This reinforces the need for routine
risk assessment in prenatal care settings and
for increased awareness that women face
risks from ex-partners5,37,38 and nonpart-
ners,39 as well as from current partners.
Consistent with other cohort studies of non-
pregnant HIV-infected women in which the
uninfected comparison women were drawn
from demographically and behaviorally simi-
lar populations,3,4,40 neither violence nor hav-
ing an abusive partner was associated with se-
rostatus. Moreover, receiving a prenatal HIV
diagnosis was not associated with elevated risk
for violence. Taken together, these findings
suggest that violence against HIV-infected
women is more likely related to the socioeco-
nomic or behavioral contexts that characterize
their lives than to serostatus itself. This is not
to say that violence is never related to HIV.
One woman was physically assaulted when
her partner learned her serostatus. Moreover,
many HIV-infected women had not disclosed
their serostatus to their partners, and we do
not know to what extent this may have been
due to fear of violence. Providers must be
aware of these risks and concerns when ad-
dressing issues of disclosure.6 However, HIV-
infected women’s risk for violence may be
best addressed by providing access to eco-
nomic and social services (e.g., financial assis-
tance, substance abuse treatment) that target
conditions known to be associated with risk of
violence. The prenatal care setting, with its
multiple scheduled provider contacts, may
provide an important opportunity for identify-
ing and referring women at risk.
These data represent a large and unique
sample of HIV-infected and at-risk pregnant
women. Nevertheless, certain limitations apply.
Women in prenatal care may be at less risk
for violence than those not in care. Moreover,
by assessing only a 6-month period of time,
some incidents of violence during pregnancy
may have been missed. At the same time, be-
cause we enrolled women as early as 24
weeks into pregnancy, some incidents of vio-
lence may have occurred in the weeks just be-
fore conception. Future research will want to
identify and address risk associated with spe-
cific pregnancy periods41 (e.g., preconception,
postpartum) as well as the impact of partner-
ship status on violence during those times.
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